These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9276018)

  • 21. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM; Traynor JR
    Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2003 Apr; 46(8):1279-82. PubMed ID: 12672226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH
    J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.
    Kawasaki AM; Knapp RJ; Walton A; Wire WS; Zalewska T; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    Int J Pept Protein Res; 1993 Nov; 42(5):411-9. PubMed ID: 7906258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 125I-DPDYN, monoiodo [D-Pro10]- dynorphin (1-11), is an effective and useful tool for the study of kappa opioid receptors.
    Gairin JE; Jomary C; Cros J; Meunier JC
    NIDA Res Monogr; 1986; 75():232-5. PubMed ID: 2893266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of dynorphin analogs substituted in positions 2 and 3.
    Schlechtingen G; DeHaven RN; Daubert JD; Cassel J; Goodman M
    Biopolymers; 2003; 71(1):71-6. PubMed ID: 12712501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
    Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
    Joshi AA; Murray TF; Aldrich JV
    J Med Chem; 2015 Nov; 58(22):8783-95. PubMed ID: 26491810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
    Story SC; Murray TF; Delander GE; Aldrich JV
    Int J Pept Protein Res; 1992 Aug; 40(2):89-96. PubMed ID: 1359999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activities of dynorphin A analogues with opioid antagonist properties.
    Gairin JE; Mazarguil H; Alvinerie P; Saint-Pierre S; Meunier JC; Cros J
    J Med Chem; 1986 Oct; 29(10):1913-7. PubMed ID: 2876099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.
    Guerrini R; Capasso A; Marastoni M; Bryant SD; Cooper PS; Lazarus LH; Temussi PA; Salvadori S
    Bioorg Med Chem; 1998 Jan; 6(1):57-62. PubMed ID: 9502105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of derivatives of leucine enkephalin as potential affinity labels for delta opioid receptors.
    Choi H; Murray TF; Aldrich JV
    Biopolymers; 2003; 71(5):552-7. PubMed ID: 14635095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes.
    Konkoy CS; Childers SR
    Mol Pharmacol; 1989 Oct; 36(4):627-33. PubMed ID: 2572962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
    Zhang A; Xiong W; Bidlack JM; Hilbert JE; Knapp BI; Wentland MP; Neumeyer JL
    J Med Chem; 2004 Jan; 47(1):165-74. PubMed ID: 14695830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel basic head-to-side-chain cyclic dynorphin A analogs: strategies and side reactions.
    Vig BS; Murray TF; Aldrich JV
    Biopolymers; 2003; 71(6):620-37. PubMed ID: 14991673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.